John Overdeck’s BioVie BIVI Stock Holding History

John Overdeck’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,412	Closed	-$24.8K	–	4591
2025 Q4	$24.8K	Sell	21,412 -11,093	-34%	-$17.9K	﹤0.01%	3983
2025 Q3	$61.8K	Buy	+32,505	New	+$132K	﹤0.01%	3524
2025 Q2	–	Sell	-2,161	Closed	-$21.2K	–	3193
2025 Q1	$21.2K	Sell	2,161 -710	-25%	-$11.4K	﹤0.01%	3097
2024 Q4	$57.4K	Buy	+2,871	New	+$69.2K	﹤0.01%	3029
2024 Q3	–	Sell	-140	Closed	-$5.63K	–	3121
2024 Q2	$5.63K	Buy	+140	New	+$6.7K	﹤0.01%	2975

Other funds holding BIVI

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

John Overdeck's BIVI Position: Q1 2026 in Review

John Overdeck sold out of BioVie (BIVI) in Q1 2026, closing a stake of 21,412 shares — an estimated $24.8K sold.

John Overdeck first reported a position in BIVI in Q2 2024 and held it in 5 quarters. The position peaked at $61.8K in Q3 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

John Overdeck reported no remaining BioVie position as of Q1 2026 after selling out during the quarter.
John Overdeck sold 21,412 BioVie shares in Q1 2026, an estimated $24.8K.
John Overdeck first reported a position in BioVie in Q2 2024 and held it in 5 quarters.
John Overdeck's BioVie position peaked at $61.8K in Q3 2025.
33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.